CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Bio-Techne Corporation

TECH
$9.07B
Mid Cap
NASDAQBiological Products, (No Diagnostic Substances)Biotechnology🇺🇸North AmericaMINNEAPOLIS3.1K employees

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

1

Next Catalyst

Aug 5, 2026

4w

Market Overview

Stock performance and key metrics

TECH News
Catalyst Timeline

1 upcoming, 0 past

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is Bio-Techne Corporation's next FDA catalyst?

Bio-Techne Corporation's (TECH) next tracked catalyst is a Earnings expected August 5, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track TECH biotech catalysts?

Add TECH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Bio-Techne Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply